Jia Jie Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	296.47	112.94	354.42	125.53	172.28
Short-Term Investments	104.06	62.06	29.74	128.21	114.03
Trading Asset Securities	81.03	88.05	-	-	-
Cash & Short-Term Investments	481.56	263.05	384.17	253.75	286.31
Cash Growth	83.07%	-31.53%	51.40%	-11.37%	-16.81%
Accounts Receivable	49.5	48.06	17.77	16.21	21.06
Other Receivables	1.83	1.85	2.82	2.78	3.38
Receivables	51.33	49.91	20.59	18.98	24.43
Inventory	27.68	24.49	24.68	26.64	20.8
Prepaid Expenses	10.8	7.98	4.99	17.23	8.65
Other Current Assets	3.12	2.91	2.89	0.61	0.1
Total Current Assets	574.48	348.34	437.31	317.21	340.28
Property, Plant & Equipment	491.8	450.75	448.81	451.21	444.91
Long-Term Investments	598.43	493.13	402.86	112.83	112.63
Goodwill	71.86	71.86	19.78	19.78	19.78
Other Intangible Assets	2.31	3.69	0.4	0.46	0.5
Long-Term Accounts Receivable	5.15	5.4	6.72	7.4	2.16
Long-Term Deferred Tax Assets	50.92	46.95	49.94	47.45	48.48
Other Long-Term Assets	93.94	62.18	47.11	47.62	52.66
Total Assets	1,889	1,482	1,413	1,004	1,021
Accounts Payable	24.46	12.46	11.27	10.3	11.72
Accrued Expenses	59.04	72.18	67.9	47.99	53.54
Short-Term Debt	50	-	237.45	-	-
Current Portion of Leases	2.43	2.46	0.81	2.53	2.29
Current Income Taxes Payable	6.61	5.28	1.57	0.38	0.91
Current Unearned Revenue	0.82	0.38	0.53	0.36	0.85
Other Current Liabilities	27.48	24.1	17.31	11.97	12.63
Total Current Liabilities	170.84	116.85	336.84	73.52	81.93
Long-Term Debt	3.61	4.03	4.7	5.18	1.51
Long-Term Leases	0.24	1.99	0.94	1.09	2.82
Other Long-Term Liabilities	0.21	0.21	0.21	0.21	0.21
Total Liabilities	174.89	123.08	342.69	80	86.47
Common Stock	1,187	987.37	889.37	889.37	889.37
Additional Paid-In Capital	251.58	91.05	58.3	57.01	57.01
Retained Earnings	340.72	349.83	163.02	18.87	24.28
Comprehensive Income & Other	-95.86	-97.23	-63.82	-67.27	-62.79
Total Common Equity	1,684	1,331	1,047	897.98	907.87
Minority Interest	30.19	28.19	23.35	25.99	27.05
Shareholders' Equity	1,714	1,359	1,070	923.96	934.92
Total Liabilities & Equity	1,889	1,482	1,413	1,004	1,021
Total Debt	56.27	8.48	243.9	8.8	6.61
Net Cash (Debt)	425.29	254.57	140.26	244.95	279.69
Net Cash Growth	67.06%	81.49%	-42.74%	-12.42%	-17.73%
Net Cash Per Share	3.65	2.59	1.57	2.75	3.14
Filing Date Shares Outstanding	118.74	98.74	88.94	88.94	88.94
Total Common Shares Outstanding	118.74	98.74	88.94	88.94	88.94
Working Capital	403.64	231.49	100.47	243.7	258.36
Book Value Per Share	14.18	13.48	11.77	10.10	10.21
Tangible Book Value	1,610	1,255	1,027	877.74	887.59
Tangible Book Value Per Share	13.56	12.72	11.54	9.87	9.98
Land	178.91	178.91	178.91	178.55	171.76
Buildings	400.52	380.85	382.81	380.89	376.79
Machinery	127.86	92.92	78.21	92.18	86.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.